Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CURX will decline by -9.58% over the next 2 Weeks and hit $0.27 by Tuesday, March 10, 2026. In that time frame, CURX's share price is expected to range between $0.25 and $0.29.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 10, 2026 | 0.25 | 0.27 | 0.29 |
| Mar 9, 2026 | 0.25 | 0.27 | 0.30 |
| Mar 6, 2026 | 0.26 | 0.28 | 0.30 |
| Mar 5, 2026 | 0.26 | 0.28 | 0.31 |
| Mar 4, 2026 | 0.26 | 0.28 | 0.31 |
| Mar 3, 2026 | 0.26 | 0.29 | 0.31 |
| Mar 2, 2026 | 0.27 | 0.29 | 0.31 |
| Feb 27, 2026 | 0.27 | 0.30 | 0.32 |
| Feb 26, 2026 | 0.28 | 0.30 | 0.32 |
| Feb 25, 2026 | 0.28 | 0.30 | 0.32 |
CURX shares rose +4.26% in Wednesday, February 25, 2026's trading session, rising from a previous close of $0.30 to move at $0.32. The stock demonstrated notable intraday movement (see CURX's key stats for a full breakdown), fluctuating between $0.30 and $0.34, a +15.89% trading range. While recent weeks have seen some volatility, CURX has managed to secure a +11.44% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 17.17M shares changing hands, 17.13M more than the previous session. This amounted to $5.42M in total market activity.
Will CURX Continue Its Downward Trend?
According to analyst ratings and projections for CURX, Curanex Pharmaceuticals Inc Common Stock shares are anticipated to decrease by -7.04%, potentially reaching $0.29 per share by March 10, 2026. Short-term technical indicators currently suggest a neutral sentiment for CURX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the CURX stock forecast, now is not the best time to buy CURX stock because its current trading price is +15.31% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CURX covering social and institutional perspectives.
CURX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CURX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.05% to 54.39%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 39.17%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 38.85%, signals a bearish bias in the long-term trend. Insights into CURX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Curanex Pharmaceuticals Common Stock Short-Term Forecasts
CURX Forecast For Next 5 Days
Our algorithm anticipates Curanex Pharmaceuticals Common Stock (CURX) stock could hit $0.28 by Mar 04, 2026. This represents a -10.21% rise from today's price, following a +3.94% change over the past five days.
CURX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Curanex Pharmaceuticals Inc Common Stock (CURX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.25, which would mean a -20.76% decrease from the current price of $0.32. Projections for this period range from a high of $0.34 to a low of $0.19.
CURX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Curanex Pharmaceuticals Common Stock's price over the next three months point to a drop. CURX stock is expected to peak at $0.42 on Feb 27, 2026 before potentially dipping to $0.00 on May 25, 2026. On average, CURX is likely to trade around $0.06 in the coming 90 days.
Curanex Pharmaceuticals Common Stock Stock Forecast 2025
Based on our predictive models, Curanex Pharmaceuticals Common Stock (CURX) is expected to trade between $0.00 and $0.42 throughout 2026. This would result in an average price of $0.02, potentially offering investors a -93.66% return from current levels.
Curanex Pharmaceuticals Inc Common Stock Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Curanex Pharmaceuticals Inc Common Stock (CURX) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.00 and $0.42, settling at an average of $0.18. This could translate to a -42.95% loss.
March 2026
Based on current market signals, Curanex Pharmaceuticals Inc Common Stock is projected to trend march 2026. We forecast a trading range from $0.00 to $0.36, with a likely average price of $0.10. Investors could expect a potential return of -68.30%.
April 2026
Our predictive algorithms indicate Curanex Pharmaceuticals Inc Common Stock stock may see a shift in April 2026. The expected range spans $0.00–$0.27, with an average target of $0.04. This represents a cautious outlook and a possible loss of -87.32%.
May 2026
Analyzing established trends, Curanex Pharmaceuticals Inc Common Stock looks set to move in May 2026. Projections place the stock between $0.00 and $0.24, averaging around $0.02. This suggests a -93.66% loss from current levels.
June 2026
Market indicators suggest Curanex Pharmaceuticals Inc Common Stock could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $0.24, with a midpoint forecast of $0.01. The stock might deliver a -96.83% loss.
July 2026
Forecasting for July 2026, models estimate that Curanex Pharmaceuticals Inc Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.24, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
August 2026
According to our latest forecast models, Curanex Pharmaceuticals Inc Common Stock (CURX) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $0.24, settling at an average of $0.00. This could translate to a -100.00% loss.
September 2026
Based on current market signals, Curanex Pharmaceuticals Inc Common Stock is projected to trend september 2026. We forecast a trading range from $0.00 to $0.25, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
October 2026
Our predictive algorithms indicate Curanex Pharmaceuticals Inc Common Stock stock may see a shift in October 2026. The expected range spans $0.00–$0.23, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
November 2026
Analyzing established trends, Curanex Pharmaceuticals Inc Common Stock looks set to move in November 2026. Projections place the stock between $0.00 and $0.24, averaging around $0.00. This suggests a -100.00% loss from current levels.
December 2026
Market indicators suggest Curanex Pharmaceuticals Inc Common Stock could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $0.23, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
January 2027
Forecasting for January 2027, models estimate that Curanex Pharmaceuticals Inc Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.22, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
February 2027
According to our latest forecast models, Curanex Pharmaceuticals Inc Common Stock (CURX) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $0.24, settling at an average of $0.00. This could translate to a -100.00% loss.
CURX's history of dividends and stock splits also plays a role in long-term investor confidence.